SARILUMAB DOSE REDUCTION TO MANAGE LABORATORY ABNORMALITIES IN AN OPEN-LABEL EXTENSION STUDY IN RA PATIENTS

被引：0

作者：

Genovese, M. C. ^{[1
]}

Fay, J. ^{[2
]}

Parrino, J. ^{[2
]}

Garg, A. ^{[3
]}

Van Hoogstraten, H. ^{[3
]}

Boddy, A. ^{[3
]}

Martincova, R. ^{[4
]}

Graham, N. ^{[5
]}

Simon, J. ^{[6
]}

Burmester, G. R. ^{[7
]}

机构：

[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA

[2] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[3] Sanofi, Bridgewater, MA USA

[4] Sanofi, Prague, Czech Republic

[5] Regeneron Pharmaceut, Tarrytown, NY USA

[6] Kohler & Milstein Res, Yucatan, Mexico

[7] Charite, Berlin, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

关键词：

D O I：

10.1136/annrheumdis-2016-eular.3709

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0228

引用

页码：515 / 516

页数：2

共 50 条

[31] Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension [J].

Barbera, Joan ;

Jansa, Pavel ;

Klings, Elizabeth ;

Ristic, Arsen ;

Keogh, Anne ;

Solum, Derek ;

Rao, Youlan ;

Grover, Rob ;

Saib, Isil ;

Sood, Namita .

ADVANCES IN THERAPY, 2024, 41 (03) :1062-1074

[32] Combination of leflunomide (LEF) and methotrexate (MTX) in patients (pts) with active rheumatoid arthritis (RA) failing MTX monotherapy - An open-label extension study [J].

Kremer, J ;

Genovese, M ;

Cannon, GW ;

Caldwell, J ;

Cush, J ;

Weisman, M ;

Luggen, ME ;

Kame, J ;

Bensen, W ;

Furst, D ;

Bathon, J ;

Keystone, F .

ARTHRITIS AND RHEUMATISM, 2001, 44 (09) :S144-S144

[33] Quetiapine in patients with Tourette's disorder: An open-label, flexible-dose study [J].

de Jonge, Jonas L. ;

Cath, Danielle C. ;

van Balkom, Anton J. L. M. .

JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (07) :1148-1150

[34] An open-label extension study to determine the safety of pimavanserin in patients with Parkinson's disease and psychosis [J].

Mills, R. ;

Johnson, A. D. ;

Bahr, D. ;

Williams, H. ;

Revell, S. .

MOVEMENT DISORDERS, 2009, 24 :S268-S269

[35] Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study [J].

Thiele, Elizabeth ;

Marsh, Eric ;

Mazurkiewicz-Beldzinska, Maria ;

Halford, Jonathan J. ;

Gunning, Boudewijn ;

Devinsky, Orrin ;

Checketts, Daniel ;

Roberts, Claire .

EPILEPSIA, 2019, 60 (03) :419-428

[36] Agomelatine in pediatric patients with moderate to severe major depressive disorder: an open-label extension study [J].

Arango, Celso ;

Fegert, Joerg M. ;

Picarel-Blanchot, Francoise ;

Marx, Ute ;

Truffaut-Chalet, Lucie ;

Penelaud, Pierre-Francois ;

Buitelaar, Jan .

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2025, 34 (05) :1603-1614

[37] Interim analysis of an open-label extension study of sustained release fampridine in patients with multiple sclerosis [J].

Goodman, A. D. ;

Brown, T. ;

Krupp, L. ;

Schapiro, R. ;

Marinucci, L. ;

Cohen, R. ;

Blight, A. .

MULTIPLE SCLEROSIS, 2009, 15 (09) :S13-S13

[38] An Open-Label Extension Study To Determine the Safety of Pimavanserin in Patients with Parkinson's Disease and Psychosis [J].

Mills, Roger ;

Johnson, Ann D. ;

Williams, Hilde ;

Bahr, Daun ;

Revell, Stephen .

NEUROLOGY, 2009, 72 (11) :A319-A319

[39] GABAPENTIN (NEURONTIN) MONOTHERAPY IN PATIENTS WITH MEDICALLY REFRACTORY PARTIAL SEIZURES - AN OPEN-LABEL EXTENSION STUDY [J].

GAROFALO, E ;

HAYES, A ;

GREELEY, C ;

HES, MK ;

MANN, M ;

GREINER, M ;

PIERCE, M .

EPILEPSIA, 1995, 36 :S119-S120

[40] Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study [J].

Iyo, Masaomi ;

Ishigooka, Jun ;

Nakamura, Masatoshi ;

Sakaguchi, Reiko ;

Okamoto, Keisuke ;

Mao, Yongcai ;

Tsai, Joyce ;

Fitzgerald, Alison ;

Takai, Kentaro ;

Higuchi, Teruhiko .

NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 :2683-2695

← 1 2 3 4 5 →